We invite you to learn about the news from Sinergium Biotech through our social networks.

Follow in:
instagram
linkedin
twitter


  • A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched today. The Argentinian manufacturer Sinergium Biotech will lead this effort leveraging the World Health Organization (WHO) and the Medicines Patent Pool (MPP) mRNA Technology Transfer […]

    Jul 2024
    Plus
  • Meeting of the WHO mRNA Technology Transfer Programme to discuss investment opportunities with multilateral development banks, hosted by PAHO.  Washington, DC – April 17, 2024 – (PAHO)- The Pan American Health Organization (PAHO) hosted a meeting of the WHO mRNA Technology Transfer Programme, with the participation of the fifteen mRNA programme members and major multilateral […]

    May 2024
    Plus
  • It was an honor for SINERGIUM Biotech, together with Fernando Lobos to have participated last March 14 in the Dialogue: Opportunities and Challenges for Increasing Vaccine Innovation and Production Capacities in Latin America and the Caribbean, held by Pan American Health Organization. Today I spoke with health technology innovation and production institutions in Latin America […]

    Mar 2024
    Plus
  • Technology transfer and tender won: Sinergium biotech creates a strong alliance with the company Sinovac in order to complete a new technology transfer for the production of the hepatitis A vaccine. The successful introduction of a vaccine into an immunization program is a significant achievement for any country, with vaccines being a fundamental tool in […]

    Nov 2023
    Plus
  • Last Friday we had the honor of receiving Jarbas Barbosa Da Silva Jr, General Director of the Pan American Health Organization and Regional Director for the Americas of the World Health Organization, at our facilities, along with a delegation of PAHO advisors, where signed a new agreement within the program to promote the development and […]

    Nov 2023
    Plus
  • During 24-26 October, we had the privilege of hosting a visit from the Medicines Patent Pool (MPP) as part of the mRNA Technology Transfer Programme. This visit marked a significant step in our ongoing efforts to strengthen our capabilities in the field of mRNA technology. The objectives of this visit encompassed several key areas:Facility Assessment: Our visitors […]

    Oct 2023
    Plus
  • Buenos Aires, October 7, 2023 (PAHO/WHO). The Director of the Pan American Health Organization (PAHO), Jarbas Barbosa, participated yesterday in the closing of the 5th World Summit on Mental Health where he emphasized the importance of integrating this issue into all public policies in order to address social determinants, economic and environmental aspects of mental […]

    Oct 2023
    Plus
  • Buenos Aires, October 3, 2023 (PAHO/WHO) – The Director of the Pan American Health Organization (PAHO), Dr. Jarbas Barbosa, held a meeting today with the President of Argentina, Alberto Fernández, in which they highlighted the need to strengthen the production of vaccines and medical supplies in Latin America and the Caribbean, in order to move […]

    Oct 2023
    Plus
  • Furthermore, as part of the official visit of the PAHO director to Argentina, Vizzotti led a meeting with him together with authorities from ANLIS Malbrán, ANMAT and ANLAP in which they worked on axes prioritized by the national government on health research and development. Within the framework of a high-level meeting with the director of […]

    Oct 2023
    Plus
  • President Alberto Fernández received today the Director of the Pan American Health Organization (PAHO), Jarbas Barbosa, and the Minister of Health, Carla Vizzotti, within the framework of the recent cooperation agreement that Argentina signed with that public health agency to increase vaccine development and production capacities, and two days before the start of the 5th […]

    Oct 2023
    Plus
Arrow

If you are part of a media outlet or journalist interested in receiving information from Sinergium Biotech, you can contact the Corporate Communication office by clicking here.